Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).

Autor: Perico N; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Remuzzi G; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Griffin MD; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland., Cockwell P; Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; Institute of Ageing and Immunity, University of Birmingham, Birmingham, United Kingdom., Maxwell AP; Queen's University Belfast Centre for Public Health, Belfast, United Kingdom., Casiraghi F; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Rubis N; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Peracchi T; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Villa A; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Todeschini M; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Carrara F; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Magee BA; Northern Ireland Histocompatibility and Immunogenetics Laboratory, Belfast City Hospital, Belfast, Northern Ireland., Ruggenenti PL; Centro di Ricerche Cliniche per le Malattie Rare 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Rota S; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Cappelletti L; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., McInerney V; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.; HRB Clinical Research Facility, University of Galway, Galway, Ireland., Griffin TP; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland., Islam MN; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland., Introna M; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Pedrini O; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy., Golay J; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Finnerty AA; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.; HRB Clinical Research Facility, University of Galway, Galway, Ireland.; Centre for Cell Manufacturing Ireland, University of Galway, Galway, Ireland., Smythe J; NHS Blood and Transplant Oxford Centre, John Radcliffe Hospital, Oxford, United Kingdom., Fibbe WE; Leiden University Medical Center, Leiden, Netherlands., Elliman SJ; Orbsen Therapeutics Ltd, Galway, Ireland., O'Brien T; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2023 Oct 01; Vol. 34 (10), pp. 1733-1751. Date of Electronic Publication: 2023 Aug 10.

Social deprivation and diabetic kidney disease: A European view.

Autor: Casey C; Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Galway, Ireland.; School of Public Health, University College Cork, Cork, Ireland., Buckley CM; School of Public Health, University College Cork, Cork, Ireland., Kearney PM; School of Public Health, University College Cork, Cork, Ireland., Griffin MD; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland.; Department of Nephrology, Galway University Hospital, Galway, Ireland., Dinneen SF; Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Galway, Ireland.; School of Medicine, University of Galway, Galway, Ireland., Griffin TP; Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Galway, Ireland.; School of Medicine, University of Galway, Galway, Ireland.

Publikováno v: Journal of diabetes investigation [J Diabetes Investig] 2024 May; Vol. 15 (5), pp. 541-556. Date of Electronic Publication: 2024 Jan 27.

Thyroid Dysfunction and Chronic Kidney Disease: Unravelling the Connection.

Autor: Griffin TP; Centre for Endocrinology, Diabetes Mellitus and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland; School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland., Griffin MD; Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre for Medical Devices, College of Medicine, Nursing and Health Sciences, University of Galway, Ireland; Renal Services, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland. Electronic address: matthew.griffin@universityofgalway.ie.

Publikováno v: Mayo Clinic proceedings [Mayo Clin Proc] 2024 Jan; Vol. 99 (1), pp. 7-9.

Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.

Autor: Crabtree TSJ; Department of Diabetes and Endocrinology, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trusts, Derby, U.K.; School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, U.K., Griffin TP; Leicester Diabetes Center, University Hospitals of Leicester, Leicester, U.K.; Diabetes Research Center, College of Health Sciences, University of Leicester, Leicester, U.K., Yap YW; Department of Diabetes and Endocrinology, Aintree University Hospital, Liverpool University Hospital NHS Foundation Trust, Liverpool, U.K., Narendran P; Department of Diabetes, The Queen Elizabeth Hospital, Birmingham, Birmingham, U.K.; The Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, U.K., Gallen G; Kings College Hospital NHS Trust, London, U.K., Furlong N; Diabetes Center, St. Helens Hospital, St. Helens and Knowsley Teaching Hospitals NHS Trust, Merseyside, U.K., Cranston I; Academic Department of Endocrinology and Diabetes Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, U.K., Chakera A; Department of Diabetes and Endocrinology, University Hospitals Sussex, Brighton, U.K.; Brighton and Sussex Medical School, Brighton, U.K., Philbey C; Department of Diabetes and Endocrinology, Harrogate and District NHS Trust, Harrogate, U.K., Karamat MA; Department of Diabetes and Endocrinology, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K., Saraf S; Department of Diabetes and Endocrinology, Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, U.K., Kamaruddin S; Department of Diabetes and Endocrinology, County Durham and Darlington Foundation Trust, Darlington, U.K., Gurnell E; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Trust, Cambridge, U.K., Chapman A; Manchester University NHS Foundation Trust, Manchester Royal Infirmary, Manchester, U.K., Hussain S; Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, U.K.; Department of Diabetes and Endocrinology, Guy's and St. Thomas' NHS Foundation Trust, London, U.K., Elliott J; Diabetes and Endocrine Center, Sheffield Teaching Hospitals, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, U.K., Leelarathna L; Manchester University NHS Foundation Trust, Manchester Royal Infirmary, Manchester, U.K., Ryder REJ; Department of Diabetes and Endocrinology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, U.K., Hammond P; Department of Diabetes and Endocrinology, Harrogate and District NHS Trust, Harrogate, U.K., Lumb A; Oxford Center for Diabetes Endocrinology and Metabolism, Oxford University Hospitals NHS Trust, Oxford, U.K.; National Institute for Health and Care Research, Oxford Biomedical Research Center, Oxford, U.K., Choudhary P; Leicester Diabetes Center, University Hospitals of Leicester, Leicester, U.K.; Diabetes Research Center, College of Health Sciences, University of Leicester, Leicester, U.K., Wilmot EG; Department of Diabetes and Endocrinology, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trusts, Derby, U.K.; School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, U.K.

Publikováno v: Diabetes care [Diabetes Care] 2023 Oct 01; Vol. 46 (10), pp. 1831-1838.

The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis.

Autor: Moran SM; Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland.; Department of Medicine, Queen's University, Kingston, Ontario, Canada., Scott J; Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland., Clarkson MR; Cork University Hospital, Ireland, University College Cork, Cork, Ireland., Conlon N; St James's Hospital, Dublin, Ireland., Dunne J; St James's Hospital, Dublin, Ireland., Griffin MD; REMEDI at CÚRAM SFI Centre for Research in Medical Devices, School of Medicine, National University of Ireland, Galway, Ireland.; Department of Nephrology, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland., Griffin TP; REMEDI at CÚRAM SFI Centre for Research in Medical Devices, School of Medicine, National University of Ireland, Galway, Ireland.; Centre for Endocrinology, Diabetes and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland., Groarke E; St James's Hospital, Dublin, Ireland., Holian J; St Vincent's University Hospital, Dublin, Ireland., Judge C; Department of Nephrology, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland.; Centre for Endocrinology, Diabetes and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland., Wyse J; Discipline of Statistics and Information Systems, Trinity College Dublin, Dublin, Ireland., McLoughlin K; St James's Hospital, Dublin, Ireland., O'Hara PV; Beaumont Kidney Centre, Dublin, Ireland., Kretzler M; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan., Little MA; Trinity Health Kidney Centre, Trinity College Dublin, Dublin, Ireland.; Beaumont Kidney Centre, Dublin, Ireland.; Tallaght University Hospital, Dublin, Ireland.

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2021 Nov; Vol. 32 (11), pp. 2920-2932. Date of Electronic Publication: 2021 Sep 13.